Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly Medicare heart failure population a retrospective, survey-weighted, cohort analysis.
Background: Heart failure (HF) management guidelines recommend that most patients with HF receive an ACE inhibitor or an angiotensin II type I receptor antagonist (angiotensin receptor blocker [ARB]) and a β-blocker (β-adrenoceptor antagonist), collectively referred to as 'cardiac drugs', based on r...
| Publicado en: | Drugs & Aging Vol. 27; no. 10; pp. 845 - 855 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |